过敏诊断和治疗市场规模、份额、增长分析、按类型、按过敏原类型、按测试类型、按地区 - 行业预测，2025-2032

Allergy Diagnostics and Therapeutics Market Size, Share, Growth Analysis, By Type (Diagnostics, Therapeutics), By Allergen Type (Food, Inhaled), By Test Type, By Region - Industry Forecast 2025-2032

出版日期: 2024年12月26日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2023年过敏诊断和治疗市场规模为306.9亿美元，从2024年的333.9亿美元成长到2032年的655.5亿美元，复合年增长率预计将成长8.8%。

由于几个关键因素，全球过敏诊断市场预计将出现强劲成长。环境污染的加剧和医疗保险的普及是这项扩张的重要因素。过敏性疾病的日益普及对经济产生了重大影响，加上过敏诊断投资的增加进一步推动了市场的成长。生活方式的改变，特别是不健康的加工食品的消费和污染的增加，对这一趋势产生了重大影响。此外，食物过敏的快速增加往往是由于饮食意识低下所致，凸显了对过敏诊断的需求不断增长。行动医疗（mHealth）技术的整合以及对创新治疗和先进诊断策略的持续研究正在加强技术进步，有望加强过敏诊断领域并带来巨大的市场机会。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争资讯

前5名企业对比
主要企业市场定位（2024年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2024年）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分類的份额分析
- 收益与前一年同期比较（2022-2024）

主要企业简介

Thermo Fisher Scientific Inc.（US）
Siemens Healthineers（Germany）
Danaher（US）
Omega Diagnostics Group PLC（UK）
bioMerieux SA（France）
Romer Labs Division Holding（Austria）
EUROIMMUN Medizinische Labordiagnostika AG（Germany）
HollisterStier Allergy（US）
NEOGEN Corporation（US）
Eurofins Scientific（Luxembourg）
Minaris Medical America Inc.（US）
HOB Biotech Group Corp. Ltd.（China）
HYCOR Biomedical（US）
R-Biopharm AG（Germany）
AESKU.GROUP GmbH（Germany）
ACON Laboratories Inc.（US）
Lincoln Diagnostics Inc.（US）
Astra Biotech GmbH（Germany）
ERBA Group（UK）

结论和建议

简介目录

Product Code: SQMIG35H2183

Allergy Diagnostics and Therapeutics Market size was valued at USD 30.69 Billion in 2023 and is poised to grow from USD 33.39 Billion in 2024 to USD 65.55 Billion by 2032, growing at a CAGR of 8.8% during the forecast period (2025-2032).

The global allergy diagnostics market is poised for robust growth driven by several key factors. Rising environmental pollution and greater healthcare insurance accessibility are vital contributors to this expansion. The increasing prevalence of allergic diseases, resulting in significant economic impact, combined with heightened investment in allergy diagnostics, further propel market growth. Lifestyle changes, particularly the intake of unhealthy processed foods and rising pollution, are major influencers on this trend. Additionally, the surge in food allergies, often stemming from poor dietary awareness, underscores the growing demand for allergy diagnostics. The integration of mobile health (mHealth) technologies and continuous research into innovative treatments and advanced diagnostic strategies present substantial market opportunities, reinforcing the technological advancements that promise to enhance the allergy diagnostics landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Allergy Diagnostics And Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Allergy Diagnostics And Therapeutics Market Segmental Analysis

Global Allergy Diagnostics and Therapeutics Market is segmented by type, allergen type, test type and region. Based on type, the market is segmented into diagnostics and therapeutics. Based on allergen type, the market is segmented into food, inhaled, drug and other allergens. Based on test type, the market is segmented into in vivo test and in vitro test. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Allergy Diagnostics And Therapeutics Market

The Allergy Diagnostics and Therapeutics market is significantly driven by the rising prevalence of allergic diseases, especially among urban populations who face a greater risk due to their exposure to environmental pollutants. This heightened incidence not only affects public health but also imposes a substantial economic burden on healthcare systems, as more individuals seek diagnosis and treatment for various allergy-related conditions. As cities continue to grow and pollution levels rise, the demand for effective diagnostic and therapeutic solutions in allergy management will likely increase, further propelling the growth of this market. Consequently, addressing allergies has become a vital public health concern.

Restraints in the Allergy Diagnostics And Therapeutics Market

The Allergy Diagnostics and Therapeutics market faces several constraints that may impede its growth trajectory. One significant challenge is the escalating costs associated with allergy diagnostic instruments, which can limit accessibility and affordability for healthcare providers and patients alike. Furthermore, the shortage of trained allergists may exacerbate these issues, hindering effective delivery of diagnostic services. This report delves into various aspects of the allergy diagnostics market, exploring recent developments, regulatory influences, and market dynamics, as well as identifying potential revenue opportunities and technological advancements. For further insights or assistance, please connect with Data Bridge Market Research for expert guidance.

Market Trends of the Allergy Diagnostics And Therapeutics Market

The Allergy Diagnostics and Therapeutics market is witnessing a robust upward trend, driven by the rising prevalence of allergic diseases globally. With factors such as urbanization, environmental pollution, and shifting dietary patterns contributing to the surge in allergic conditions, healthcare systems are increasingly focused on effective diagnostic methods and innovative therapeutic solutions. Advancements in technology-ranging from enhanced testing kits to targeted biologics-are improving the accuracy and efficiency of allergy management. This rising awareness and demand for personalized treatment options are propelling market growth, making it essential for stakeholders to adapt to evolving patient needs and environmental challenges in this dynamic landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis

Global Allergy Diagnostics and Therapeutics Market Size by Type & CAGR (2024-2032)

Market Overview
Diagnostics
- Instruments
- Consumables
- Services
Therapeutics
- Antihistamines
- Decongestants
- Corticosteroids
- Mast Cell Stabilizers
- Leukotriene Inhibitors
- Nasal Anti-Cholinergic
- Immuno-Modulators
- Epinephrine
- Immunotherapy

Global Allergy Diagnostics and Therapeutics Market Size by Allergen Type & CAGR (2024-2032)

Market Overview
Food
- Dairy Products
- Poultry Product
- Tree Nuts
- Peanuts
- Shellfish
- Wheat
- Soys
- Other Food Allergens
Inhaled
Drug
Other Allergens

Global Allergy Diagnostics and Therapeutics Market Size by Test Type & CAGR (2024-2032)

Market Overview
In Vivo Test
- Skin Prick Test
- Intradermal Test
- Patch Test
In Vitro Test

Global Allergy Diagnostics and Therapeutics Market Size & CAGR (2024-2032)

North America (Type, Allergen Type, Test Type)
- US
- Canada
Europe (Type, Allergen Type, Test Type)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Allergen Type, Test Type)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Allergen Type, Test Type)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Allergen Type, Test Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omega Diagnostics Group PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Romer Labs Division Holding (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EUROIMMUN Medizinische Labordiagnostika AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HollisterStier Allergy (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NEOGEN Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Minaris Medical America Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HOB Biotech Group Corp. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HYCOR Biomedical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
R-Biopharm AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AESKU.GROUP GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lincoln Diagnostics Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astra Biotech GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ERBA Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments